NovaBay Pharmaceuticals, Inc.
NovaBay Pharmaceuticals, Inc. (NBY) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · NBY · as of Jun 8, 2026
Key Statistics
Explore NovaBay Pharmaceuticals, Inc. Data
nby stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 5 · Buy rate: 40.0%
Competitors & Peers
nby competitorsNBY
ADXN
IBO
KTTA
MTNB
PMCBStock Performance
Full HistoryAbout NovaBay Pharmaceuticals, Inc.
NovaBay Pharmaceuticals, Inc. (NBY) is a pharmaceutical company that specializes in developing and globally distributing products for eyecare and dermatology. Its product portfolio includes Avenova, a…
what is novabay pharmaceuticals, inc. · nby stock overview · novabay pharmaceuticals, inc. company profile · who is novabay pharmaceuticals, inc. ceo · nby AMEX · novabay pharmaceuticals, inc. headquarters · novabay pharmaceuticals, inc. business segments
About Stock Overview & Key Data
NovaBay Pharmaceuticals, Inc. (NBY) is a Healthcare company in the Biotechnology industry, listed on AMEX since Oct 26, 2007. As of the latest trading session, NBY stock price is $1.47, with a market capitalization of $39.1M. The stock has returned -50.51% over the past 12 months and -94.79% year-to-date.
According to 5 Wall Street analysts, the consensus rating for NovaBay Pharmaceuticals, Inc. stock is Hold, with an average 12-month price target of $—. In fiscal year 2025, NovaBay Pharmaceuticals, Inc. reported revenue of — and net income of -$22.1M. For detailed data — including NovaBay Pharmaceuticals, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, NovaBay Pharmaceuticals, Inc. (NBY) stock price is $1.47. The stock is traded on AMEX under the ticker symbol NBY. The 52-week range is $1.11 – $99.75.